PPG to support EuroSkills Herning 2025 vocational skills competition
7.4.2025 16:00:00 CEST | Business Wire | Press Release
PPG (NYSE:PPG) today announced that it will support EuroSkills Herning 2025, Europe’s largest vocational skills competition, which takes place Sept. 9-13, 2025, in Herning, Denmark. As the Main Skill Sponsor for the Painting and Decorating competition, the company will provide financial support and will also supply SIGMA COATINGS™ paints and PROGOLD™ sundries by PPG.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250407512504/en/
From left: Torben Beck, PPG general manager, Scandinavia and DACH, Architectural Coatings; Kasper Bøgelund, head of competitions, EuroSkills Herning 2025; and Christian Corlin, chief operating officer, EuroSkills Herning 2025, during a visit to the PPG shop in Søborg, Denmark as part of the collaboration agreement signing ceremony.
The partnership underscores PPG’s commitment to supporting vocational education and training to shape the workforce of tomorrow. The event will bring together up to 600 young professionals from 33 countries who will compete across 38 skill areas over three days. With the theme “Skilled for a Greener Future,” the competition highlights the vital role of technical and vocational skills in driving sustainability and innovation. Held every two years, EuroSkills provides an important platform to inspire young professionals and showcase industry excellence.
“Vocational education and training are essential for developing a highly skilled workforce and EuroSkills Herning 2025 provides a unique platform to showcase young talent,” said Torben Beck, PPG general manager, Scandinavia and DACH, Architectural Coatings. “At PPG, we recognize that supporting these young professionals is an investment in the future of our industry. We are proud to contribute to their learning journey by providing high-performance coatings that help them hone their skills and prepare for successful careers.”
Participants in the Painting and Decorating competition will be challenged to demonstrate expertise in surface preparation, wallpapering, decorative finishes and color matching. PPG will also support EuroSkills experts, who will assess the competitors' work done using PPG’s premium products, including SigmaCoatings WallPrimer Plus with packaging made from 90% recycled plastic and EU Ecolabel.
PPG’s support of EuroSkills Herning 2025 is part of its broader commitment to investing in education and workforce development. In 2023, PPG and the PPG Foundation announced a $2 million investment to support training programs, curriculum development and career readiness resources for students and educators.
“The growing skills gap in vocational professions requires companies, educators and policymakers to work together to ensure that young people have access to the right resources and training,” said Christian Corlin, chief operating officer, EuroSkills Herning 2025. “Strong industry partnerships are essential to the success of EuroSkills Herning 2025, and we are thrilled to have PPG as a key supporter. Its expertise and high-performance paints and coatings will provide competitors with the tools they need to demonstrate their skills at the highest level. With PPG’s support, we can continue to inspire and prepare young professionals for successful careers in skilled trades.”
To learn more about EuroSkills Herning 2025, visit: https://euroskills2025.com.
PPG’s global community engagement efforts and the PPG Foundation aim to bring color and brightness to PPG communities around the world. We invested $18.4 million in 2024, supporting hundreds of organizations across more than 30 countries. By investing in educational opportunities, we help grow tomorrow’s STEM innovators and skilled workforce in fields related to coatings and manufacturing. Plus, we empower PPG employees to multiply their impact for causes that are important to them by supporting their volunteer efforts and charitable giving. Learn more here.
PPG: WE PROTECT AND BEAUTIFY THE WORLD®
At PPG (NYSE:PPG), we work every day to develop and deliver the paints, coatings and specialty materials that our customers have trusted for more than 140 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $15.8 billion in 2024. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com.
The PPG Logo and We protect and beautify the world are registered trademarks of PPG Industries Ohio, Inc.
Sigma Coatings and ProGold are registered trademarks of PPG Nederland B.V.
CATEGORY Community Affairs
View source version on businesswire.com: https://www.businesswire.com/news/home/20250407512504/en/
Contacts
PPG Media Contact:
Andrew Wood
Corporate Communications, EMEA
+31 6 5121 6579
awood@ppg.com
www.ppg.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ppg.com&esh
eet=54233540&newsitemid=20250407512504&lan=en-US&anchor=www.ppg.com&index=4&md5=
46df30be754e72568f5bb3150c459d80
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom